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ommunity level day-3 positive surveillance of Plasmodium fal-
iparum malaria in Cambodia
. Say1,∗, S. Bjorge2, M. Sokkhieng1, L. Dysoley3, K. Soy Ty1
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WHO Cambodia, Phnom Penh, Cambodia
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Background: The Cambodia-Thai border area has been the epi-
enter ofmalaria parasite resistance to various anti-malarial drugs.
he USAID Malaria Control Project in Cambodia implemented by
niversity Research Co., LLC and other partners with funding from
HO conducted a pilot study of community day-3 surveillance of
lasmodium falciparum parasite in two health centers catchment
reas from September 2010 to November 2011. Village Malaria
orkers (VMWs) play very crucial role in providing an early
iagnosis and appropriate treatment in their community. VMWs
ere asked to play an additional role in smear making and direct
bserved therapy.
Methods: Fifty-six VMWswere trained on the use of rapid diag-
ostic tests (RDT) for all suspected malaria cases, smear making for
onﬁrmed P. falciparum, and malaria treatment. Health center staff
rganized a regular monthly meeting of VMWs at the health cen-
er to share information and distribute supplies such as RDTs and
rtemisinin combination therapy to the VMWs. For each conﬁrmed
. falciparum case, the VMWs did two smears - on Day 0 and Day
- and sent the slides to the health center laboratory for reading.
MWs provided direct observed therapy for all enrolled malaria
ases. Travel and treatment historieswere recordedbyVMWs.Data
n all Day-3 positive cases was sent by SMS to staff at the district
nd central levels for further investigation.
Results: VMWs enrolled 264 P. falciparum and 24 P. falciparum
lus P. vivax cases in the surveillance. Three-quarters (76%) of
ases were male, mostly between 15-49 years. One quarter (24%)
ere mobile and migrant workers. Fifty-six of 288 enrolled cases
emained positive on Day-3 (17%) and received further investi-
ation and treatment. An external evaluation supported by WHO
ound the quality of VMW diagnosis and treatment to be of high
uality.
Conclusion:Theuseof communityvolunteers forDay-3 surveil-
ance is feasible and can have high quality results. This pilot proves
hat Day-3 positivity, an early warning sign of potential multi-drug
esistance, can be captured at community level.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.090nfectious Diseases 16S (2012) e2–e157 e35
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Background: The border area between Cambodia and Thailand
has long been the epicenter of malaria parasites resistant to var-
ious anti-malarial drugs. The USAID Malaria Control in Cambodia
project (MCC) implemented by University Research Co., LLC and its
partners are conducting a mapping of multi-drug resistant (MDR)
malaria cases at twohospitals inwestern Cambodia to better deﬁne
the geographical distribution of potential drug resistant carriers.
Methods: During the 32-month study (May-2009 to September
2011), 142 hospitalized patients diagnosed with P. falciparum were
included in the study. Follow-up of the patientswas extended to 28
days after treatment in order to identify resistant infection. History
of travel, permanent address, and clinical information of patients
were recorded by hospital staff. During patient follow-up visits, a
blood smear and dry spots were collected and sent to the referral
hospital’s laboratory and to the reference laboratory. GPS was used
for geographical mapping of residence or location where malaria
patients got infected.
Results: The proportion of Day-3 positive patients based on
microscopywas estimated to 54% in Battambang and 43% inAnlong
Veng. Among the 78 patients correctly treated and followed-up for
28 days, 43% in Battambang and 9% in Anlong Veng were classiﬁed
as failed (at D21 or D28) based on PCR detection of malaria para-
sites. No signiﬁcant difference of IC50 between the two sites was
found, suggesting the existence of a parasite ﬂow between the two
sites. Furthers analysis is needed to correlate this information to
the travel history of patients and particularly the location of the
likely infection.
Conclusion: Declining artemisinin efﬁcacy in western Cambo-
dia is evidenced by slower parasite clearance in patients and high
failure rates.We foundpoorcorrelationbetween the treatmentout-
comes, Day-3 positivity, and in vitro drug susceptibility. Parasites
resistant to artemisinins are emerging at a time when we have no
methodology to study it in vitro and have no predictive molecular
marker. The study also found the higher emergence of particular
genotype in recrudescent patients and the existence of a gene ﬂow
of these particular genotypes between the two sites.
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